The 2025-2030 World Outlook for Minimally Invasive Devices

The 2025-2030 World Outlook for Minimally Invasive Devices

This study covers the world outlook for minimally invasive devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

In this report we define the sales of minimally invasive devices as including all commonly understood products falling within this broad category, such as needle, retractor, trocar, forceps, tapler, catheter, guidewire, cannula, and metal shaft surgical equipment; magnetic resonance imaging (MRI) scanner, computerized tomography (CT) scanner, x-ray, and ultrasound monitoring and visualization equipment; robotic assisted Da Vinci System and Zeus Robotic Surgical System; pencil, electrode, bipolar forceps, electrosurgical accessory, suction coagulator, laparoscopic electrosurgical equipment; endoscopy, laparoscopy, robot-assisted method, arthroscopic technique devices; cryo, radio-frequency, microwave, embolization, and irreversible electroporation ablation method devices; and devices for cardiac, colorectal, dermatological, ears, nose, throat (ENT), gastrointestinal, gynecologic, lung and respiratory care, neuro, ophthalmology, orthopedic, urological, and weight loss surgeries, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include 3Smith & Nephew, PLC, 4 Surgical Innovations Group, PLC, 5 MGB Endoskopische Gerate GmbH Berlin, 6 REMA Medizintechnik GmbH, 8 Sagentia, Inc., Abbott Laboratories, Arthrex, Arthro Care Corporation, Biomet, Boston Scientific, Cardinal Health, Covidien, Fujifilm Holding, GE Healthcare, IBA Group, Intuitive Surgical, Johnson & Johnson, Karl Storz, Lantheus Medical Imaging, MAKO Surgical, Mallinckrodt, Medtronic,, Inc., Nordion,, Inc., NovaTract Surgical, Inc., Ntp Radioisotopes (Pty), Omniguide Surgical, Richard Wolf, Siemens Healthcare, Stryker Corporation U.S, Teleflex,, Inc., Triad Isotope, and Zimmer Holdings. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).